- Article metrics
- Last updated: Tue, 20 May 2025 3:46:58 Z
Cost-effectiveness of sacituzumab govitecan for hormone receptor-positive human epidermal growth factor receptor 2-negative metastatic breast cancer based on the EVER-132-002 trial in China
Access & Citations
-
- 532
- Article Accesses
-
- Data not available
- Web of Science
-
- Data not available
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.